Robert F. Mauer

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

Washington Gas Light Co. is a regulated public utility company, which engages in the natural gas distribution business. It offers regulated distribution of natural gas to retail customers under tariff rates designed to provide for a return on the investment used in providing that service. The company was founded in 1848 and is headquartered in Washington, DC.

Washington Gas Light Co. is a regulated public utility company, which engages in the natural gas distribution business. It offers regulated distribution of natural gas to retail customers under tariff rates designed to provide for a return on the investment used in providing that service. The company was founded in 1848 and is headquartered in Washington, DC.

Washington Gas Light Co. is a regulated public utility company, which engages in the natural gas distribution business. It offers regulated distribution of natural gas to retail customers under tariff rates designed to provide for a return on the investment used in providing that service. The company was founded in 1848 and is headquartered in Washington, DC.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.